These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21742025)

  • 1. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.
    Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R
    Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry.
    Romoli R; Papaleo MC; de Pascale D; Tutino ML; Michaud L; LoGiudice A; Fani R; Bartolucci G
    J Mass Spectrom; 2011 Oct; 46(10):1051-9. PubMed ID: 22012672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analysis of three sponge-associated Arthrobacter Antarctic strains, inhibiting the growth of Burkholderia cepacia complex bacteria by synthesizing volatile organic compounds.
    Orlandini V; Maida I; Fondi M; Perrin E; Papaleo MC; Bosi E; de Pascale D; Tutino ML; Michaud L; Lo Giudice A; Fani R
    Microbiol Res; 2014; 169(7-8):593-601. PubMed ID: 24231161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Draft genomes of three Antarctic Psychrobacter strains producing antimicrobial compounds against Burkholderia cepacia complex, opportunistic human pathogens.
    Fondi M; Orlandini V; Perrin E; Maida I; Bosi E; Papaleo MC; Michaud L; Lo Giudice A; de Pascale D; Tutino ML; Liò P; Fani R
    Mar Genomics; 2014 Feb; 13():37-8. PubMed ID: 24401162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive volatile organic compounds from Antarctic (sponges) bacteria.
    Papaleo MC; Romoli R; Bartolucci G; Maida I; Perrin E; Fondi M; Orlandini V; Mengoni A; Emiliani G; Tutino ML; Parrilli E; de Pascale D; Michaud L; Lo Giudice A; Fani R
    N Biotechnol; 2013 Sep; 30(6):824-38. PubMed ID: 23619351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
    Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
    N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Activity of Monoramnholipids Produced by Bacterial Strains Isolated from the Ross Sea (Antarctica).
    Tedesco P; Maida I; Palma Esposito F; Tortorella E; Subko K; Ezeofor CC; Zhang Y; Tabudravu J; Jaspars M; Fani R; de Pascale D
    Mar Drugs; 2016 Apr; 14(5):. PubMed ID: 27128927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.
    Chiellini C; Maida I; Maggini V; Bosi E; Mocali S; Emiliani G; Perrin E; Firenzuoli F; Mengoni A; Fani R
    Microbiol Res; 2017 Mar; 196():34-43. PubMed ID: 28164789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic interactions between psychrotrophic cultivable bacteria isolated from Antarctic sponges: a preliminary analysis.
    Mangano S; Michaud L; Caruso C; Brilli M; Bruni V; Fani R; Lo Giudice A
    Res Microbiol; 2009; 160(1):27-37. PubMed ID: 19013518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, characterization and phylogeny of sponge-associated bacteria with antimicrobial activities from Brazil.
    Santos OC; Pontes PV; Santos JF; Muricy G; Giambiagi-deMarval M; Laport MS
    Res Microbiol; 2010 Sep; 161(7):604-12. PubMed ID: 20600863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.
    Fondi M; Orlandini V; Maida I; Perrin E; Papaleo MC; Emiliani G; de Pascale D; Parrilli E; Tutino ML; Michaud L; Lo Giudice A; Fani R
    J Bacteriol; 2012 Nov; 194(22):6334-5. PubMed ID: 23105071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
    Van Acker H; Van Snick E; Nelis HJ; Coenye T
    J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex.
    Tabacchioni S; Ferri L; Manno G; Mentasti M; Cocchi P; Campana S; Ravenni N; Taccetti G; Dalmastri C; Chiarini L; Bevivino A; Fani R
    FEMS Microbiol Lett; 2008 Apr; 281(2):175-82. PubMed ID: 18312571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
    J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.